Literature DB >> 23445914

Sclerostin and DKK1 levels during 14 and 21 days of bed rest in healthy young men.

P Frings-Meuthen1, G Boehme, A-M Liphardt, N Baecker, M Heer, J Rittweger.   

Abstract

OBJECTIVES: Wnt signaling pathway may be crucial in the pathogenesis of disuse-induced bone loss. Sclerostin and DKK1, antagonists of the Wnt signaling pathway, were assessed during immobilization by bed rest in young, healthy people.
METHODS: Two bed rest studies were conducted at the German Aerospace Center in Cologne. 14 days of 6° head-down-tilt bed rest were applied to eight healthy young male test subjects in study 1 and 21 days of head-down-tilt bed rest to seven healthy male subjects in study 2.
RESULTS: Sclerostin levels increased in both studies during bed rest (study 1, 0.64±0.05 ng/ml to 0.69±0.04 ng/ml, P=0.014; study 2, 0.42±0.04 ng/ml to 0.47±0.04 ng/ml, P=0.008) and they declined at the end of the 14- and 21-day bed rest periods. DKK1 decreased during the bed rest period in study 1 (P<0.001) but increased during bed rest in study 2 (P=0.006). As expected, bone formation marker PINP decreased (study 1, P=0.013; study 2, P<0.001) and bone resorption marker NTX increased during bed rest (P<0.001).
CONCLUSION: Data suggest that the Wnt signaling pathway is involved in disuse-induced bone loss in young, healthy humans.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23445914

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  19 in total

1.  Acute bone changes after lower limb amputation resulting from traumatic injury.

Authors:  D A Bemben; V D Sherk; W J J Ertl; M G Bemben
Journal:  Osteoporos Int       Date:  2017-04-01       Impact factor: 4.507

2.  Serum sclerostin and DKK1 in relation to exercise against bone loss in experimental bed rest.

Authors:  Daniel L Belavý; Natalie Baecker; Gabriele Armbrecht; Gisela Beller; Judith Buehlmeier; Petra Frings-Meuthen; Jörn Rittweger; Heinz J Roth; Martina Heer; Dieter Felsenberg
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

3.  DI-5-Cuffs: Bone Remodelling and Associated Metabolism Markers in Humans After Five Days of Dry Immersion to Simulate Microgravity.

Authors:  Marie-Thérèse Linossier; Laura Peurière; Peter Fernandez; Myriam Normand; Arnaud Beck; Marie-Pierre Bareille; Christine Bonneau; Guillemette Gauquelin-Koch; Laurence Vico
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

Review 4.  Skeletal changes during and after spaceflight.

Authors:  Laurence Vico; Alan Hargens
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 5.  Hormonal and systemic regulation of sclerostin.

Authors:  Matthew T Drake; Sundeep Khosla
Journal:  Bone       Date:  2016-12-10       Impact factor: 4.398

Review 6.  Clinical utility of serum sclerostin measurements.

Authors:  Bart L Clarke; Matthew T Drake
Journal:  Bonekey Rep       Date:  2013-06-05

Review 7.  Calcium homeostasis during hibernation and in mechanical environments disrupting calcium homeostasis.

Authors:  Yasir Arfat; Andleeb Rani; Wang Jingping; Charles H Hocart
Journal:  J Comp Physiol B       Date:  2020-01-03       Impact factor: 2.200

Review 8.  Spaceflight-Induced Bone Tissue Changes that Affect Bone Quality and Increase Fracture Risk.

Authors:  Jennifer C Coulombe; Bhavya Senwar; Virginia L Ferguson
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

9.  Elevated circulating Sclerostin concentrations in individuals with high bone mass, with and without LRP5 mutations.

Authors:  Celia L Gregson; Kenneth E S Poole; Eugene V McCloskey; Emma L Duncan; Jörn Rittweger; William D Fraser; George Davey Smith; Jonathan H Tobias
Journal:  J Clin Endocrinol Metab       Date:  2014-02-25       Impact factor: 5.958

10.  Assessment of lumbar intervertebral disc glycosaminoglycan content by gadolinium-enhanced MRI before and after 21-days of head-down-tilt bedrest.

Authors:  Timmo Koy; Jochen Zange; Jörn Rittweger; Regina Pohle-Fröhlich; Matthias Hackenbroch; Peer Eysel; Bergita Ganse
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.